ANGELA ROGERS: Open Payments
NPI 1871960948 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 57 payments from 15 companies in 2025. Trend: 2023 $856 · 2024 $1,308 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $240 |
| Amgen Inc. | 13 | $228 |
| Corcept Therapeutics | 11 | $160 |
| Insulet Corporation | 3 | $57 |
| Echosens North America, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| Medtronic, Inc. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: Korlym, TEPEZZA, Rybelsus, Ozempic, Omnipod, EVENITY, Fibroscan, Kerendia.
Industry payments across KY — which companies pay providers there.
